Javascript is not enabled in your web browser

This site uses javascript to enhance your browsing experience. Our vision tests require javascript and will not work properly if javascript is disabled. Please enable javascript in your web browser to access all features of this site.

Welcome to MyVisionTest.com, where patients with macular degeneration and other macular diseases can test their vision online. We offer our services free of charge. To use our test online you must first register here. Read the tutorial to learn more.

This site has been designed to be accessible by the visually impaired. Should you have any difficulties, please contact us.

TEST YOUR VISION NOW

Featured Articles

Select Article:
Vitreous

Vitrectomy slows progression of AMD

It is fairly well established that the vitreous plays a role in the progression of AMD. However, this is the first study that finds that the progression of AMD can be slowed by vitrectomy. Microplasmin, a new drug that can cause the vitreous to dissolve, eliminates vitreoretinal adhesions and is being tested as a treatment for vitreomacular...

Polypoidal choroidal vasculopathy

AMD and polypoidal choroidal vasculopathy are genetically similar

The genetic similarities between AMD and PCV suggests that these conditions are simply different manifestations of the same underlying disease. PCV is much more common in Asians than Caucasians, possibly due to genetic difference in these two populations. It has been reported that about 75% of Asians with neovascular AMD have macular polyps....

VEGF molecule

VEGF165b inhibits CNV in mice

Although most isoforms of VEGF promote neovascularization ("bad VEGF"), there is at least one isoform, VEGF-A165b, that acts to inhibit CNV ("good VEGF"). Current anti-VEGF drugs, such as Lucentis and Avastin, inhibit all isoforms of VEGF (good and bad). Unfortunately, about 10% of people with AMD do not respond to Lucentis and Avastin therapy. It...

DNA double-helix molecule

RNAi-based treatment for neovascular AMD by Sirna-027

This exciting new treatment modality is based on the principle of RNA interference. RNA acts as a messenger within the cell, carrying instructions from DNA within the cell's nucleus out to locations within the cell where the genetic instructions are used to build proteins. Interfering RNA intercepts and destroys the messenger RNA for specific...

Recent News

Lucentis
Aug 29, 2010
Lucentis was safe and effective with quarterly (and then monthly) dosing during the 2-year Phase IIIb PIER study of subjects with neovascular age-related macular degeneration (AMD), accordingto a new report from the study. Lucentis provided significant visual acuity (VA) benefit in patients with AMD-related CNV compared with sham injection....

Full Article


Vitreous
Aug 29, 2010
Vitrectomy decreases the progression of age-related macular degeneration (AMD), according to a new research study. There is no published evidence that a vitrectomy hastens the progression of AMD. Intraocular surgery is known however to incite significant inflammation and breakdown of the blood–ocular barrier, which may last from weeks to...

Full Article


Polypoidal choroidal vasculopathy
Aug 29, 2010
The polypoidal choroidal vasculopathy (PCV) phenotype in Caucasian patients is associated with the major alleles in three age-related macular degeneration (AMD)-associated loci, suggesting that PCV and AMD are genetically similar, according to a new research study. Polypoidal choroidal vasculopathy (PCV) is characterized by aneurysmal dilations...

Full Article


News Topics

ADL skills adverse drug effects AMD angioid streaks animal study AREDS aspirin Avastin blindness cardiovascular disease cataract CATT central serous chorioretinopathy choroid clinical trial CNV combo therapy complement depression diabetes diabetic retinopathy diet dosing strategy drug delivery drusen dry AMD eccentric viewing economics fat fish fluorescein angiography fundus autofluorescence genetics glaucoma histoplasmosis ICGA inflammation integrin ischemia Japan laser photocoagulation low vision Lucentis lutein Macugen macular edema microplasmin mobility myopia OCT PDGF photodynamic therapy pigment epithelial derived factor pigment epithelial detachment polypoidal choroidal vasculopathy prognosis PrONTO Quality of life radiation reading skills retinal angiomatous proliferation retinal pigment epithelium retinal prosthesis retinal vein occlusion retinitis pigmentosa risk factors RNA interference stem cells steroid surgery telangiectasia tobacco UK uveitis VEGF VEGF Trap vision test vitreous wet AMD women
More topics

About MyVisionTest

MyVisionTest.com has been developed to supplement the traditional Amsler Grid for those patients that have been instructed by their eye doctor to monitor their vision at home. MyVisionTest employs a technique known as entoptic perimetry to detect defects in your vision. Research has found entoptic perimetry to be superior to the traditional Amsler grid in detecting such defects. We also offer you the ability to save and review past test results, making it easier for you to detect changes in your vision over time.

Learn more

MyVisionTest Tutorial

If you are new to MyVisionTest, please take a moment to review our tutorial and try out the demo. The vision test requires that you have free multimedia software (Flash) installed and properly configured on your computer. If you are uncertain whether this software is currently installed on your computer, please take a moment to use our troubleshooter to test your system for compatibility with MyVisionTest.

View the MyVisionTest Tutorial

Test your computer for compatibility with MyVisionTest

MyVisionTest Demonstration Mode

Download Amsler Grid